Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,040 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel combined C-reactive protein-albumin ratio and modified albumin-bilirubin score can predict long-term outcomes in patients with hepatocellular carcinoma after hepatic resection.
Aida T, Haruki K, Akaoka M, Furukawa K, Onda S, Shirai Y, Shiozaki H, Takahashi K, Oikawa T, Ikegami T. Aida T, et al. Among authors: oikawa t. Ann Gastroenterol Surg. 2023 Aug 10;8(1):143-150. doi: 10.1002/ags3.12727. eCollection 2024 Jan. Ann Gastroenterol Surg. 2023. PMID: 38250682 Free PMC article.
Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma.
Nakagawa C, Oikawa T, Yamada K, Tsubota A, Saeki C, Katagiri K, Tago N, Kamioka H, Ueda K, Haruki K, Furukawa K, Nakano M, Torisu Y, Ikegami T, Yoshida K, Saruta M. Nakagawa C, et al. Among authors: oikawa t. Biomarkers. 2024 Mar;29(2):55-67. doi: 10.1080/1354750X.2024.2312990. Epub 2024 Feb 15. Biomarkers. 2024. PMID: 38361436 Free article.
Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma.
Oikawa T, Yamada K, Tsubota A, Saeki C, Tago N, Nakagawa C, Ueda K, Kamioka H, Taniai T, Haruki K, Nakano M, Torisu Y, Ikegami T, Yoshida K, Saruta M. Oikawa T, et al. Gastro Hep Adv. 2022 Aug 5;2(1):83-95. doi: 10.1016/j.gastha.2022.07.020. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39130149 Free PMC article.
Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.
Kawaratani H, Kondo Y, Tatsumi R, Kawabe N, Tanabe N, Sakamaki A, Okumoto K, Uchida Y, Endo K, Kawaguchi T, Oikawa T, Ishizu Y, Hige S, Takami T, Terai S, Ueno Y, Mochida S, Takikawa Y, Torimura T, Matsuura T, Ishigami M, Koike K, Yoshiji H. Kawaratani H, et al. Among authors: oikawa t. J Clin Med. 2022 Mar 12;11(6):1571. doi: 10.3390/jcm11061571. J Clin Med. 2022. PMID: 35329897 Free PMC article.
The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C.
Toyoda H, Atsukawa M, Uojima H, Nozaki A, Takaguchi K, Hiraoka A, Itobayashi E, Watanabe T, Matsuura K, Shimada N, Abe H, Tsuji K, Itokawa N, Mikami S, Ishikawa T, Oikawa T, Yasuda S, Chuma M, Tsutsui A, Ikeda H, Arai T, Tsubota A, Kumada T, Tanaka Y, Tanaka J. Toyoda H, et al. Among authors: oikawa t. Gastro Hep Adv. 2022 Apr 29;1(4):508-515. doi: 10.1016/j.gastha.2022.02.018. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39132067 Free PMC article.
1,040 results